Fortrea Completes Acquisition of the Early Phase Services Division from Worldwide Clinical Trials
Expands Fortrea’s early clinical development network with dedicated bioanalytical capabilities, increased clinical research unit capacity and a more integrated platform for clients Highlights Fortrea completes acquisition of the Early Phase Services division from Worldwide Clinical Trials Adds a 60,000-square-foot GLP-compliant bioanalytical laboratory in Austin, Texas; a 200-bed GCP-compliant…
We haven't written up this one. Financial Post has the full story — the link below goes straight to it.
